Gene · 8754
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ADAM9 deubiquitination induced by USP22 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition of trophoblast cells in preeclampsia. | Placenta | 2024 | 38176298 | PubTator, text mining | PubMed |
| Hsa_circ_0001583 fuels bladder cancer metastasis by promoting staphylococcal nuclease and tudor domain containing 1-mediated MicroRNA decay. | Neoplasia | 2024 | 38176295 | PubTator, text mining | PubMed |
| Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. | Theranostics | 2024 | 38169544 | PubTator, text mining | PubMed |
| Histone acetylation in an Alzheimer's disease cell model promotes homeostatic amyloid-reducing pathways. | Acta Neuropathol Commun | 2024 | 38167174 | PubTator, text mining | PubMed |
| Revealing profile of cancer-educated platelets and their factors to foster immunotherapy development. | Transl Oncol | 2024 | 38134841 | PubTator, text mining | PubMed |
| Circ_0061140 Potentiates Clear Cell Renal Cell Carcinoma Progression Via the MicroRNA-126-5p/ADAM9 Axis. | Mol Biotechnol | 2024 | 38062234 | PubTator, text mining | PubMed |
| Listen to Your Gut: Key Concepts for Bioengineering Advanced Models of the Intestine. | Adv Sci (Weinh) | 2024 | 38009508 | PubTator, text mining | PubMed |
| Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage-Myofibroblast Transition in Non-Small-Cell Lung Carcinoma. | Adv Sci (Weinh) | 2024 | 37967345 | PubTator, text mining | PubMed |
| RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression. | Genes Dis | 2024 | 37588203 | PubTator, text mining | PubMed |
| Functional characteristics of DNA N6-methyladenine modification based on long-read sequencing in pancreatic cancer. | Brief Funct Genomics | 2024 | 37279592 | PubTator, text mining | PubMed |
| Role of ATG7-dependent non-autophagic pathway in angiogenesis. | Front Pharmacol | 2023 | 38269279 | PubTator, text mining | PubMed |
| The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery. | Biomedicines | 2023 | 38255186 | PubTator, text mining | PubMed |
| TAMs and PD-1 Networking in Gastric Cancer: A Review of the Literature. | Cancers (Basel) | 2023 | 38201623 | PubTator, text mining | PubMed |
| Circular RNAs in breast cancer diagnosis, treatment and prognosis. | Oncol Res | 2023 | 38186573 | PubTator, text mining | PubMed |
| Development of artificial bone graft via in vitro endochondral ossification (ECO) strategy for bone repair. | Mater Today Bio | 2023 | 38161510 | PubTator, text mining | PubMed |
| Lung Fibroblasts from Chronic Obstructive Pulmonary Disease Subjects Have a Deficient Gene Expression Response to Cigarette Smoke Extract Compared to Healthy. | Int J Chron Obstruct Pulmon Dis | 2023 | 38143920 | PubTator, text mining | PubMed |
| miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy. | Curr Issues Mol Biol | 2023 | 38132441 | PubTator, text mining | PubMed |
| Mir-142-3P regulates MAPK protein family by inhibiting 14-3-3η to enhance bone marrow mesenchymal stem cells osteogenesis. | Sci Rep | 2023 | 38129425 | PubTator, text mining | PubMed |
| Nanopore Single-molecule Analysis of Biomarkers: Providing Possible Clues to Disease Diagnosis. | Trends Analyt Chem | 2023 | 38106545 | PubTator, text mining | PubMed |
| Identification of novel immune cell signature in gastroesophageal reflux disease: altered mucosal mast cells and dendritic cell profile. | Front Immunol | 2023 | 38098488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8754/papers?page=6